The most commonly mutated genes of the TGF-β signaling pathway include TGFBR1, TGFBR2, SMAD4, and SMAD2. The significance of the TGF-β signaling pathway in cancer was recently confirmed by a report of TCGA (The Cancer Genome Atlas) consortium. This evidence concerns the gene TGFBR2 and cancer.